Abstract

COVID19 Vaccine Acceptance and Hesitancy in Low-and-middle-income Countries

Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is just beginning. We analyze COVID-19 vaccine acceptance across 15 survey samples covering 10 low- and middle-income countries (LMICs) in Asia, Africa and South America, Russia (an upper-middle-income country) and the United States, including a total of 44,260 individuals. We find considerably higher willingness to take a COVID-19 vaccine in our LMIC samples (mean 80.3%; median 78%; range 30.1 percentage points) compared with the United States (mean 64.6%) and Russia (mean 30.4%). Vaccine acceptance in LMICs is primarily explained by an interest in personal protection against COVID-19, while concern about side effects is the most common reason for hesitancy. Health workers are the most trusted sources of guidance about COVID-19 vaccines. Evidence from this sample of LMICs suggests that prioritizing vaccine distribution to the Global South should yield high returns in advancing global immunization coverage. returns in advancing global immunization coverage


Author(s):                       Fayomi Segun Alex                   .

Abstract | PDF

Share This Article
17+ Million Readerbase
Recommended Conferences
Google Scholar citation report
Citations : 1

Clinical Immunology and Infectious Diseases received 1 citations as per Google Scholar report

Abstracted/Indexed in
  • Google Scholar

View More »

Flyer image